Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
| Brand name | NICARDIPINE HYDROCHLORIDE |
| Generic name | NICARDIPINE HYDROCHLORIDE |
| Active ingredient(s) | NICARDIPINE HYDROCHLORIDE |
| Distributed by / for | American Regent, Inc. |
| NDC | 72572-470-01 |
| Full product label | niCARdipine Hydrochloride Injection, USP, 25 mg/10mL (2.5 mg/mL), packaged in a) 10 mL Single Dose Vial (NDC 72572-470-01) and b) 10x10 mL Single Dose Vials (NDC 72572-470-10), Rx Only, Mfd for: Civica, Inc., Lehi, UT, Mfd by: American Regent, Inc., New Albany, OH 43054. |
| Recalling firm | American Regent, Inc. |
| Distribution | Nationwide within the U.S |
| Quantity | 43,460 vials |
| Recall initiated | 2026-07-24 |
| Report date | 2026-08-26 |
| Recall completed | — |
| Recall number | D-0802-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Shirley NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗